Institutional Ownership Erasca, Inc. (ERAS)
This table provides information about the institutional ownership of Erasca, Inc. (ERAS). We have compiled data on the 149 institutions that hold shares in the stock, with a total of 217 Million shares, which have been reported (via 13F filing form) to have a value of $338 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Aug 14, 2025 Q2 2025 |
22,729,436
shares
|
$35.5 Million
1.52% of portfolio
|
Q2 2025
Added 0.68%
|
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
20,332,161
shares
|
$31.7 Million
0.02% of portfolio
|
Q2 2025
Added 17.58%
|
|
|
Vr Adviser, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
17,857,083
shares
|
$27.9 Million
4.49% of portfolio
|
Q2 2025
Added 10.12%
|
|
|
Logos Global Management LP
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
15,000,000
shares
|
$23.4 Million
2.46% of portfolio
|
Q2 2025
Added 15.38%
|
|
|
Suvretta Capital Management, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
14,502,004
shares
|
$22.6 Million
0.63% of portfolio
|
Q2 2025
Added 17.76%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
12,695,597
shares
|
$19.8 Million
0.0% of portfolio
|
Q2 2025
Reduced 0.25%
|
|
|
Paradigm Biocapital Advisors LP
New York, NY |
Aug 14, 2025 Q2 2025 |
11,907,182
shares
|
$18.6 Million
0.71% of portfolio
|
Q2 2025
Added 10.23%
|
|
|
Arch Venture Management, LLC
Chicago, IL |
Aug 14, 2025 Q2 2025 |
11,055,554
shares
|
$17.2 Million
7.44% of portfolio
|
Q4 2021
New holding
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
10,611,346
shares
|
$16.6 Million
0.0% of portfolio
|
Q2 2024
Added 52.0%
|
|
|
Siren, L.L.C.
New York, NY |
Aug 13, 2025 Q2 2025 |
8,757,249
shares
|
$13.7 Million
0.58% of portfolio
|
Q1 2025
Reduced 1.13%
|
|
|
Vivo Capital, LLC
Palo Alto, CA |
Aug 13, 2025 Q2 2025 |
6,756,756
shares
|
$10.5 Million
1.82% of portfolio
|
Q2 2024
New holding
|
|
|
5 Am Venture Management, LLC
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
5,405,404
shares
|
$8.43 Million
4.61% of portfolio
|
Q2 2024
New holding
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
4,835,642
shares
|
$7.54 Million
0.0% of portfolio
|
Q2 2025
Added 1.63%
|
|
|
Affinity Asset Advisors, LLC
New York, NY |
Aug 13, 2025 Q2 2025 |
4,085,787
shares
|
$6.37 Million
0.87% of portfolio
|
Q2 2025
Added 22.27%
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
4,002,110
shares
|
$6.24 Million
0.0% of portfolio
|
Q2 2025
Reduced 4.21%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Aug 14, 2025 Q2 2025 |
3,797,987
shares
|
$5.92 Million
0.0% of portfolio
|
Q2 2025
Added 17.78%
|
|
|
Silverarc Capital Management, LLC
|
Aug 14, 2025 Q2 2025 |
2,569,591
shares
|
$4.01 Million
0.79% of portfolio
|
Q2 2025
Reduced 65.12%
|
|
|
Ah Equity Partners Bio Ii, L.L.C.
Menlo Park, CA |
Nov 14, 2022 Q3 2022 |
2,500,000
shares
|
$3.9 Million
13.59% of portfolio
|
Q4 2021
New holding
|
|
|
Soleus Capital Management, L.P.
Greenwich, CT |
Aug 14, 2025 Q2 2025 |
2,162,162
shares
|
$3.37 Million
0.21% of portfolio
|
Q2 2024
New holding
|
|
|
Marshall Wace, LLP
London, X0 |
Aug 13, 2025 Q2 2025 |
2,074,425
shares
|
$3.24 Million
0.0% of portfolio
|
Q2 2025
Added 2.34%
|
|
|
Woodline Partners LP
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
2,074,390
shares
|
$3.24 Million
0.01% of portfolio
|
Q2 2025
Reduced 49.98%
|
|
|
International Biotechnology Trust PLC
London, X0 |
Nov 14, 2023 Q3 2023 |
1,926,000
shares
|
$3 Million
1.29% of portfolio
|
Q3 2023
Added 35.06%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
1,819,849
shares
|
$2.84 Million
0.0% of portfolio
|
Q2 2025
Reduced 6.01%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Aug 12, 2025 Q2 2025 |
1,696,593
shares
|
$2.65 Million
0.0% of portfolio
|
Q2 2025
Added 17.68%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Aug 12, 2025 Q2 2025 |
1,693,423
shares
|
$2.64 Million
0.0% of portfolio
|
Q2 2025
Reduced 7.87%
|